ACAD
Price
$23.59
Change
-$0.94 (-3.83%)
Updated
Sep 23, 04:59 PM (EDT)
Capitalization
4.14B
49 days until earnings call
RXRX
Price
$4.80
Change
-$0.18 (-3.61%)
Updated
Sep 23, 04:59 PM (EDT)
Capitalization
2.17B
43 days until earnings call
Interact to see
Advertisement

ACAD vs RXRX

Header iconACAD vs RXRX Comparison
Open Charts ACAD vs RXRXBanner chart's image
ACADIA Pharmaceuticals
Price$23.59
Change-$0.94 (-3.83%)
Volume$24.87K
Capitalization4.14B
Recursion Pharmaceuticals
Price$4.80
Change-$0.18 (-3.61%)
Volume$283.2K
Capitalization2.17B
ACAD vs RXRX Comparison Chart in %
Loading...
ACAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACAD vs. RXRX commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACAD is a Hold and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (ACAD: $24.53 vs. RXRX: $4.98)
Brand notoriety: ACAD and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACAD: 95% vs. RXRX: 141%
Market capitalization -- ACAD: $3.98B vs. RXRX: $2.17B
ACAD [@Biotechnology] is valued at $3.98B. RXRX’s [@Biotechnology] market capitalization is $2.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACAD’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • ACAD’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, ACAD is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACAD’s TA Score shows that 5 TA indicator(s) are bullish while RXRX’s TA Score has 6 bullish TA indicator(s).

  • ACAD’s TA Score: 5 bullish, 4 bearish.
  • RXRX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than ACAD.

Price Growth

ACAD (@Biotechnology) experienced а -0.57% price change this week, while RXRX (@Biotechnology) price change was +4.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.94%. For the same industry, the average monthly price growth was +8.31%, and the average quarterly price growth was +48.45%.

Reported Earning Dates

ACAD is expected to report earnings on Nov 11, 2025.

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACAD($4.14B) has a higher market cap than RXRX($2.17B). ACAD YTD gains are higher at: 33.678 vs. RXRX (-26.331). ACAD has higher annual earnings (EBITDA): 104M vs. RXRX (-583.64M). ACAD has more cash in the bank: 762M vs. RXRX (525M). ACAD has less debt than RXRX: ACAD (56.3M) vs RXRX (88.1M). ACAD has higher revenues than RXRX: ACAD (1.02B) vs RXRX (64.5M).
ACADRXRXACAD / RXRX
Capitalization4.14B2.17B190%
EBITDA104M-583.64M-18%
Gain YTD33.678-26.331-128%
P/E Ratio18.44N/A-
Revenue1.02B64.5M1,580%
Total Cash762M525M145%
Total Debt56.3M88.1M64%
FUNDAMENTALS RATINGS
ACAD: Fundamental Ratings
ACAD
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
29
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACADRXRX
RSI
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 6 days ago
74%
Bullish Trend 15 days ago
85%
Declines
ODDS (%)
Bearish Trend 19 days ago
69%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 5 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ACAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VAFNX36.660.18
+0.49%
Invesco American Franchise R5
CSCRX34.700.14
+0.41%
Columbia Small Cap Growth Inst2
BFIIX18.370.03
+0.17%
Baron FinTech Institutional
APHLX15.590.01
+0.06%
Artisan Value Institutional
FIKAX50.49N/A
N/A
Fidelity Advisor Energy Z

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+1.43%
CRSP - RXRX
68%
Closely correlated
-0.35%
ABSI - RXRX
63%
Loosely correlated
+3.07%
BEAM - RXRX
61%
Loosely correlated
+0.37%
ABCL - RXRX
58%
Loosely correlated
+7.10%
NTLA - RXRX
55%
Loosely correlated
+10.71%
More